P62827 (RAN_MOUSE) Mus musculus (Mouse)
GTP-binding nuclear protein Ran UniProtKBInterProSTRINGInteractive Modelling
216 aa; Sequence (Fasta) ;
90 identical sequences
It is possible new templates exist for this target since these models were created.
Available Structures
141 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal Structure of Nucleoporin NUP50 Ran-Binding Domain in Complex with Ran-GPPNHP |
Heteromer P62826; Q9UKX7; | 100 | 1×GNP; 1×MG; | |||
| MVM NES mutant Nm2 in complex with CRM1-Ran-RanBP1 |
Heteromer P0DJZ2; P30822; P41920; P62826; | 99.52 | 1×GTP; 1×MG; 1×EDO; 1×GOL; 1×NA; | |||
| MVM NES mutant Nm12 in complex with CRM1-Ran-RanBP1 |
Heteromer P0DJZ2; P30822; P41920; P62826; | 99.52 | 1×GTP; 1×MG; 1×EDO; 2×GOL; 1×CL; 1×NA; | |||
| Crystal Structure of Nup358/RanBP2 Ran-binding domain 1 in complex with Ran-GPPNHP |
Heteromer P49792; P62826; | 100 | 1×GNP; 1×MG; | |||
| MVM NS2 mutant Nm42 in complex with CRM1-Ran-RanBP1 |
Heteromer P0DJZ2; P30822; P41920; P62826; | 99.52 | 1×GTP; 1×MG; 1×EDO; 2×GOL; 1×NA; | |||
| MVM NES mutant Nm13 in complex with CRM1-Ran-RanBP1 |
Heteromer P0DJZ2; P30822; P41920; P62826; | 99.52 | 1×GTP; 1×MG; 1×EDO; 2×GOL; 1×NA; | |||
| MVM NS2 NES in complex with CRM1-Ran-RanBP1 |
Heteromer P0DJZ2; P30822; P41920; P62826; | 99.52 | 1×GTP; 1×MG; 1×EDO; 2×GOL; 1×NA; | |||
| MVM NES mutant Nm15 in complex with CRM1-Ran-RanBP1 |
Heteromer P0DJZ2; P30822; P41920; P62826; | 99.52 | 1×GTP; 1×MG; | |||
| Crystal Structure of Nup358/RanBP2 Ran-binding domain 3 in complex with Ran-GPPNHP |
Heteromer P49792; P62826; | 100.0 | 1×GNP; 1×MG; | |||
| Crystal structure of CRM1 inhibitor Leptomycin B in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 100 | 1×GNP; 1×MG; 3×EDO; 1×LMB; 2×GOL; 4×CL; | |||
| Crystal structure of KPT276 in complex with CRM1-Ran-RanBP1 |
Heteromer P41920; P62826; | 100 | 1×GNP; 1×MG; 2×EDO; 4×GOL; 1×K76; 3×CL; | |||
| Crystal Structure of KPT-330 bound to CRM1 (537-DLTVK-541 to GLCEQ) |
Heteromer P30822; P41920; P62826; | 100.0 | 1×GNP; 1×MG; 1×GOL; 1×V6A; | |||
| Crystal structure of CRM1 inhibitor Leptomycin B in complex with CRM1(537DLTVK541/GLCEQ)-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 100 | 1×GNP; 1×MG; 2×EDO; 1×LMB; 1×GOL; 4×CL; | |||
| Crystal Structure of mDia2 NES Peptide in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; Q9NSV4; | 100 | 1×GNP; 1×MG; 3×GOL; | |||
| Yeast CRM1e (apo) in complex with Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 98.56 | 1×MG; 2×GOL; 1×GTP; 12×CL; 2×DMS; 1×MPO; | |||
| Crystal Structure of CPEB4 NES Peptide in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; Q17RY0; | 100 | 1×GNP; 1×MG; 7×GOL; 1×CL; | |||
| Crystal structure of KPT185 in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 100.0 | 1×GNP; 1×MG; 2×EDO; 1×K85; 6×GOL; 3×CL; | |||
| B27 in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 99.04 | 1×MG; 5×GOL; 1×GTP; 3×DMS; 2×CL; 1×M9R; | |||
| F1 in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 99.04 | 1×MG; 4×GOL; 1×GTP; 3×CL; 3×DMS; 1×N59; | |||
| Zafirlukast in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 98.56 | 1×MG; 6×DMS; 8×EDO; 1×GTP; 4×CL; 1×NA; 2×GOL; 1×MPO; 1×ZLK; | |||
| G6 in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 99.04 | 1×MG; 2×GOL; 1×GTP; 11×CL; 2×DMS; 1×MPO; 1×MBI; | |||
| Crystal structure of CRM1 inhibitor Ratjadone A in complex with CRM1(K579A)-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 100.0 | 1×RJA; 3×GOL; 3×EDO; 3×CL; 1×GNP; 1×MG; | |||
| B28 in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 99.04 | 1×MG; 3×GOL; 1×GTP; 1×BR; 1×CL; 1×NA; 1×N5X; | |||
| RanY197A in complex with RanBP1-CRM1 |
Heteromer P30822; P41920; P62826; | 99.52 | 1×GTP; 1×MG; 1×EDO; 7×CL; 3×GOL; 2×ACT; | |||
| RanL182A in complex with RanBP1-CRM1 |
Heteromer P30822; P41920; P62826; | 99.52 | 1×GTP; 2×MG; 1×EDO; 1×GOL; 4×CL; | |||
| LFS829 in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 99.51 | 1×GTP; 1×MG; 1×D29; 1×CL; | |||
| Oridonin in complex with CRM1#-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 99.04 | 1×MG; 1×EDO; 1×GTP; 4×CL; 3×ODN; | |||
| Crystal Structure of the ZnF1 of Nucleoporin NUP153 in complex with Ran-GDP |
Heteromer P49791; P62826; | 99.51 | 1×GDP; 1×MG; 1×ZN; | |||
| NCI-1 in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 99.04 | 1×MG; 1×GTP; 6×DMS; 9×CL; 1×G6U; 1×GOL; 1×MPO; | |||
| Crystal structure of CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 100.0 | 1×GNP; 1×MG; 4×GOL; 2×EDO; 4×CL; | |||
| Crystal structure of CRM1 inhibitor Leptomycin B in complex with CRM1(R543S,K548E,K579Q)-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 100.0 | 1×GNP; 1×MG; 5×CL; 1×LBF; | |||
| Crystal structure of CRM1 inhibitor Leptomycin B in complex with CRM1(K548A)-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 100.0 | 1×GNP; 2×MG; 3×GOL; 2×EDO; 1×LMB; 3×CL; | |||
| Crystal Structure of KPT-185 bound to CRM1 (E582K, 537-DLTVK-541 to GLCEQ) |
Heteromer P30822; P41920; P62826; | 100.0 | 1×GNP; 1×MG; 1×K85; | |||
| Crystal Structure of KPT-330 bound to CRM1 (E582K, 537-DLTVK-541 to GLCEQ) |
Heteromer P30822; P41920; P62826; | 100 | 1×GNP; 1×MG; 2×GOL; 1×V6A; | |||
| Crystal structure of CRM1 inhibitor Ratjadone A in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 100.0 | 1×GNP; 1×MG; 4×EDO; 1×RJA; 3×GOL; 3×CL; | |||
| Crystal structure of CRM1 inhibitor Anguinomycin A in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 100.0 | 1×GNP; 1×MG; 4×CL; 1×AA8; | |||
| Crystal Structure of MVM NS2 NES Peptide in complex with CRM1-Ran-RanBP1 |
Heteromer P0DJZ2; P30822; P41920; P62826; | 100.0 | 1×GNP; 1×MG; 6×GOL; 1×CL; | |||
| KL2 in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 99.04 | 1×MG; 14×NO3; 5×GOL; 1×GTP; 1×GLU; 2×CL; 4×DMS; 1×MFF; | |||
| RanM189D in complex with RanBP1-CRM1 |
Heteromer P30822; P41920; P62826; | 99.52 | 1×GTP; 2×MG; 1×EDO; 6×CL; 5×GOL; | |||
| KL1 in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 99.04 | 1×MG; 17×NO3; 6×GOL; 1×GTP; 1×CL; 7×DMS; 1×MI8; | |||
| Crystal Structure of HDAC5 NES Peptide in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; Q9UQL6; | 100 | 1×GNP; 1×MG; 4×GOL; | |||
| Crystal Structure of DEAF1 Peptide in complex with CRM1 K579A mutant-Ran-RanBP1 |
Heteromer O75398; P30822; P41920; P62826; | 100.0 | 1×GNP; 1×MG; 3×GOL; | |||
| Plumbagin in complex with CRM1#-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 99.04 | 1×MG; 3×GOL; 9×NO3; 1×GTP; 3×CL; 3×DMS; 3×F2X; | |||
| Crystal Structure of KPT-8602 bound to CRM1 (E582K, 537-DLTVK-541 to GLCEQ) |
Heteromer P30822; P41920; P62826; | 100 | 1×GNP; 1×MG; 1×6L8; | |||
| Crystal structure of CRM1 inhibitor Leptomycin B in complex with CRM1(K541Q,K542Q,R543S,K545Q,K548Q… |
Heteromer P30822; P41920; P62826; | 100.0 | 1×GNP; 1×MG; 1×LBF; 4×CL; | |||
| Crystal Structure of PKINES peptide bound to CRM1 |
Heteromer P30822; P41920; P61925; P62826; | 100.0 | 1×GNP; 1×MG; 2×GOL; | |||
| Crystal structure of KPT251 in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 100 | 1×GNP; 1×MG; 2×EDO; 5×CL; 1×51K; 3×GOL; | |||
| Crystal Structure of FMRP NES Peptide in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; Q06787; | 100.0 | 1×GNP; 1×MG; 3×GOL; | |||
| Crystal Structure of SMAD4 NES Peptide in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; Q13485; | 100 | 1×GNP; 1×MG; 3×GOL; 1×CL; | |||
| Crystal Structure of CDC7 NES Peptide (extended) in complex with CRM1-Ran-RanBP1 |
Heteromer O00311; P30822; P41920; P62826; | 100.0 | 1×GNP; 1×MG; 3×GOL; 1×CL; | |||
| Crystal Structure of Paxillin NES Peptide in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P49023; P62826; | 100.0 | 1×GNP; 1×MG; 3×GOL; | |||
| Crystal Structure of CDC7 NES Peptide in complex with CRM1-Ran-RanBP1 |
Heteromer O00311; P30822; P41920; P62826; | 100.0 | 1×GNP; 1×MG; 4×GOL; | |||
| Crystal Structure of hRio2 NES Reverse Mutant Peptide in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 100 | 1×GNP; 1×MG; 4×GOL; 1×ZN; 1×CL; | |||
| Crystal Structure of hRio2 NES Peptide in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; Q9BVS4; | 100.0 | 1×GNP; 1×MG; 4×GOL; 2×CL; 1×ZN; | |||
| Crystal Structure of the 4E-TNES peptide bound to CRM1 |
Heteromer P30822; P41920; P62826; Q9NRA8; | 100.0 | 1×GNP; 1×MG; 3×GOL; | |||
| KL2.1 in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 99.04 | 1×MG; 14×NO3; 9×DMS; 5×GOL; 1×GTP; 1×CL; 1×ACT; 1×Q73; | |||
| Crystal structure of CRM1 inhibitor Leptomycin B in complex with CRM1(K548E,K579Q)-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 100.0 | 1×GNP; 1×MG; 5×EDO; 1×LMB; 3×CL; | |||
| Plumbagin in complex with CRM1-RanM189D-RanBP1 |
Heteromer P30822; P41920; P62826; | 99.52 | 1×GTP; 1×MG; 2×CL; 4×NO3; 2×F2X; 1×NA; | |||
| Crystal Structure of mDia2NES peptide bound to CRM1(E571K) |
Heteromer P30822; P41920; P62826; Q9NSV4; | 100.0 | 1×GNP; 1×MG; 3×GOL; 1×EDO; | |||
| Crystal Structure of Hxk2 Peptide in complex with CRM1 K579A mutant-Ran-RanBP1 |
Heteromer P04807; P30822; P41920; P62826; | 100 | 1×GNP; 1×MG; 4×GOL; | |||
| Crystal Structure of Engineered FMRP-1b NES Peptide in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; Q06787; | 100.0 | 1×GNP; 1×MG; 2×GOL; | |||
| Crystal Structure of unliganded CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 100 | 1×GNP; 1×MG; 1×GOL; | |||
| Crystal Structure of X11L2 NES Peptide in complex with CRM1-Ran-RanBP1 |
Heteromer O96018; P30822; P41920; P62826; | 100.0 | 1×GNP; 1×MG; 3×GOL; | |||
| Crystal Structure of the Mek1NES peptide bound to CRM1 |
Heteromer P30822; P41920; P62826; Q02750; | 100.0 | 1×GNP; 1×MG; 3×GOL; | |||
| Crystal Structure of KPT-8602 bound to CRM1 (537-DLTVK-541 to GLCEQ) |
Heteromer P30822; P41920; P62826; | 100 | 1×GNP; 1×MG; 1×6L8; | |||
| Crystal Structure of Mek1NES peptide bound to CRM1(E571K) |
Heteromer P30822; P41920; P62826; Q02750; | 100.0 | 1×GNP; 1×MG; 3×GOL; | |||
| Crystal Structure of Mek1(NQ)NES peptide bound to CRM |
Heteromer P30822; P41920; P62826; Q02750; | 100.0 | 1×GNP; 1×MG; 3×GOL; | |||
| Crystal Structure of KPT8602 in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 100.0 | 1×GNP; 1×MG; 5×GOL; 1×CL; 1×6L8; | |||
| S109 in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 100 | 1×GTP; 1×MG; 5×NO3; 1×CL; 1×EQF; 1×GOL; | |||
| Crystal Structure of PKI NES Flip Mutant Peptide in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P61925; P62826; | 100.0 | 1×GNP; 1×MG; 3×GOL; | |||
| Crystal Structure of unliganded CRM1(E571K)-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 100 | 1×GNP; 1×MG; | |||
| Crystal structure of CRM1(T539S)-Ran-RanBP1 with weakly bound unmodeled Leptomycin B |
Heteromer P30822; P41920; P62826; | 100.0 | 1×GNP; 1×MG; 1×CL; | |||
| Crystal Structure of KPT-185 bound to CRM1 (537-DLTVK-541 to GLCEQ) |
Heteromer P30822; P41920; P62826; | 100 | 1×GNP; 1×MG; 1×K85; | |||
| Crystal Structure of PKI(DE)NES peptide bound to CRM1 |
Heteromer P30822; P41920; P61925; P62826; | 100.0 | 1×GNP; 1×MG; 2×GOL; | |||
| Crystal Structure of CPEB4 NES Reverse Mutant Peptide in complex with CRM1-Ran-RanBP1 |
Heteromer P30822; P41920; P62826; | 100.0 | 1×GNP; 1×MG; 3×GOL; | |||
| Crystal Structure of PKINES peptide bound to CRM1(E571K) |
Heteromer P30822; P41920; P61925; P62826; | 100.0 | 1×GNP; 1×MG; 3×GOL; | |||
| Crystal Structure of Nup358/RanBP2 Ran-binding domain 2 in complex with Ran-GPPNHP |
Heteromer P49792; P62826; | 100 | 1×GNP; 1×MG; | |||
| Ran Y39A in complex with GPPNHP and RanBD1 |
Heteromer P49792; P62826; | 99.52 | 1×GNP; 1×MG; 3×SO4; | |||
| Crystal Structure of Nup358/RanBP2 Ran-binding domain 4 in complex with Ran-GPPNHP |
Heteromer P49792; P62826; | 100 | 1×GNP; 1×MG; | |||
| Structure of the NTF2:RanGDP complex |
Heteromer P61972; P62825; | 100.0 | 3×GDP; 3×MG; 1×SO4; | |||
| Crystal structure of Ran-GPPNHP-RanBP1-RanGAP complex |
Heteromer P41391; P43487; P62826; | 100 | 1×MG; 1×GNP; | |||
| Crystal structure of Ran-GDP-AlFx-RanBP1-RanGAP complex |
Heteromer P41391; P43487; P62826; | 100 | 1×MG; 1×GDP; 1×AF3; | |||
| Human RANBP2/RAN(GTP)/RANGAP1-SUMO1/UBC9/CRM1/RAN(GTP) - composite map and model |
Heteromer O14980; P46060; P49792; P62826; P63165; P63279; | 99.42 | 2×GTP; 2×MG; | |||
| Crystal structure of human RanGDP-Nup153ZnF34 complex |
Heteromer P49791; P62826; | 99.51 | 2×MG; 1×GDP; 1×ZN; | |||
| Crystal Structure of the ZnF3 of Nucleoporin NUP153 in complex with Ran-GDP, resolution 2.05 Angstr… |
Heteromer P49791; P62826; | 99.51 | 1×GDP; 1×MG; 1×ZN; | |||
| Crystal Structure of the ZnF3 of Nucleoporin NUP153 in complex with Ran-GDP, resolution 2.4 Angstrom |
Heteromer P49791; P62826; | 99.51 | 1×GDP; 1×MG; 1×ZN; | |||
| STRUCTURE OF THE RAN-GPPNHP-RANBD1 COMPLEX |
Heteromer P49792; P62826; | 100 | 1×MG; 1×GNP; | |||
| Crystal Structure of the ZnF8 of Nucleoporin NUP358/RanBP2 in complex with Ran-GDP |
Heteromer P49792; P62826; | 99.51 | 1×GDP; 1×GOL; 1×MG; 1×ZN; | |||
| Crystal Structure of the ZnF3 of Nucleoporin NUP358/RanBP2 in complex with Ran-GDP |
Heteromer P49792; P62826; | 99.51 | 1×GDP; 1×MG; 1×ZN; | |||
| Crystal structure of human RanGDP-Nup153ZnF1 complex |
Heteromer P49791; P62826; | 99.51 | 1×MG; 1×GDP; 1×ZN; | |||
| Crystal Structure of the ZnF4 of Nucleoporin NUP153 in complex with Ran-GDP |
Heteromer P49791; P62826; | 99.5 | 1×GDP; 1×MG; 1×ZN; | |||
| Crystal structure of human RanGDP-Nup153ZnF2 complex |
Heteromer P49791; P62826; | 100 | 1×MG; 1×GDP; 1×ZN; | |||
| Crystal Structure of the ZnF2 of Nucleoporin NUP358/RanBP2 in complex with Ran-GDP |
Heteromer P49792; P62826; | 99.5 | 1×GDP; 1×MG; 1×ZN; | |||
| Crystal Structure of the ZnF4 of Nucleoporin NUP358/RanBP2 in complex with Ran-GDP |
Heteromer P49792; P62826; | 99.5 | 1×GDP; 1×MG; 1×ZN; | |||
| Crystal Structure of the ZnF2 of Nucleoporin NUP153 in complex with Ran-GDP |
Heteromer P49791; P62826; | 99.5 | 1×GDP; 1×MG; 1×ZN; | |||
| Crystal structure of human RanGDP-Nup153ZnF4 complex |
Heteromer P49791; P62826; | 99.5 | 1×MG; 1×GDP; 1×ZN; | |||
| Crystal structure of human RanGDP-Nup153ZnF12 complex |
Heteromer P49791; P62826; | 99.5 | 3×MG; 1×GDP; 1×ZN; | |||
| Crystal Structure of the ZnF2 of Nucleoporin NUP358/RanBP2 in complex with Ran-GDP |
Heteromer P49792; P62826; | 99.5 | 1×GDP; 1×MG; 1×ZN; | |||
| Crystal structure of human RanGDP-Nup153ZnF3 complex |
Heteromer P49791; P62826; | 99.5 | 1×MG; 1×GDP; 1×ZN; | |||
| Crystal Structure of the ZnF5 or ZnF6 of Nucleoporin NUP358/RanBP2 in complex with Ran-GDP |
Heteromer P49792; P62826; | 99.5 | 1×GDP; 1×MG; 1×ZN; | |||
| Crystal Structure of the ZnF7 of Nucleoporin NUP358/RanBP2 in complex with Ran-GDP |
Heteromer P49792; P62826; | 99.5 | 1×GDP; 1×MG; 1×ZN; | |||
| The crystal structure of the RanGDP-Nup153ZnF2 complex |
Heteromer P49791; P62826; | 100.0 | 4×MG; 4×SO4; 4×GDP; 4×ZN; | |||
| STRUCTURE OF THE KARYOPHERIN BETA2-RAN GPPNHP NUCLEAR TRANSPORT COMPLEX |
Heteromer P62826; Q92973; | 100 | 1×MG; 1×GNP; | |||
| Truncated Ran wild type in complex with GDP-BeF and RanBD1 |
Heteromer P49792; P62826; | 100 | 1×GDP; 1×BEF; 1×MG; | |||
| Human CRM1-RanGTP in complex with Leptomycin B |
Heteromer O14980; P62826; | 99.43 | 1×GTP; 1×MG; 1×LMB; | |||
| Kap95p Binding Induces the Switch Loops of RanGDP to adopt the GTP-bound Conformation: Implications… |
Heteromer P62826; Q06142; | 100 | 1×GDP; 2×MG; | |||
| Crystal structure of human CRM1 covalently modified by 2-mercaptoethanol at Cys528 |
Heteromer O14980; P62826; | 99.42 | 1×GTP; 1×MG; 1×BME; | |||
| Crystal structure of the HIV-1 Rev NES-CRM1-RanGTP nuclear export complex (crystal I) |
Heteromer O95149; P62826; Q6P5F9; | 99.42 | 1×GTP; 1×MG; 1×NA; | |||
| Crystal structure of the HIV-1 Rev NES-CRM1-RanGTP nuclear export complex (crystal II) |
Heteromer O95149; P62826; Q6P5F9; | 99.42 | 8×GOL; 11×PEG; 1×IPH; 2×GTP; 2×MG; | |||
| Crystal structure of RanGTP-Exportin 4-eIF5A complex |
Heteromer P62826; P63241; Q9ESJ0; | 99.42 | 1×GTP; 1×MG; | |||
| Crystal structure of the CRM1-RanGTP complex |
Heteromer P62826; Q6P5F9; | 99.42 | 1×GTP; 1×MG; | |||
| Crystal structure of a CRM1-RanGTP-SPN1 export complex bound to a 113 amino acid FG-repeat containi… |
Heteromer O14980; O95149; P0AEX9; P35658; P62826; | 99.42 | 1×GLC; 2×PRO; 1×GTP; 1×MG; | |||
| Crystal structure of transportin-SR2, a karyopherin involved in human disease, in complex with Ran |
Heteromer P62826; Q9Y5L0; | 100 | 1×MG; 1×GTP; | |||
| Crystal Structure of the Nuclear Export Complex CRM1-Snurportin1-RanGTP |
Heteromer O95149; P62826; Q6P5F9; | 99.42 | 1×NA; 1×GTP; 1×MG; | |||
| Crystal structure of Kap121p bound to RanGTP |
Heteromer P32337; P62825; | 100 | 1×MG; 1×GTP; | |||
| Crystal structure of the biportin Pdr6 in complex with RanGTP |
Heteromer P32767; P62826; | 99.42 | 1×GTP; 1×MG; | |||
| Crystal structure of the PKI NES-CRM1-RanGTP nuclear export complex |
Heteromer O95149; P62826; Q6P5F9; | 99.42 | 1×GTP; 1×MG; | |||
| Crystal structure of RanGTP-Pdr6-eIF5A export complex |
Heteromer P23301; P32767; P62826; | 99.42 | 1×GTP; 1×MG; | |||
| Cryo-EM structure of Ran bound to RCC1 and the nucleosome core particle |
Heteromer P02283; P02299; P18754; P62826; P84040; P84051; | 100.0 | ||||
| RAN-RCC1-SO4 COMPLEX |
Heteromer P18754; P62826; | 100.0 | 1×SO4; | |||
| Structure of the Cse1:Imp-alpha:RanGTP complex |
Heteromer P33307; P62825; Q02821; | 100 | 1×GTP; 1×MG; | |||
| Crystal structure of Exportin-5:RanGTP:pre-miRNA complex |
Heteromer P62825; Q9HAV4; | 100 | 1×GTP; 1×MG; | |||
| CRYSTAL STRUCTURE OF EXPORTIN-5:RANGTP COMPLEX |
Heteromer P62825; Q9HAV4; | 100 | 1×GTP; 1×MG; | |||
| COMPLEX OF RAN WITH IMPORTIN BETA |
Heteromer P62826; Q14974; | 100 | 1×MG; 1×GNP; | |||
| Kap95p:RanGTP complex |
Heteromer P62825; Q06142; | 99.41 | 1×GTP; 1×MG; | |||
| Transportin 3 in complex with Ran(Q69L)GTP |
Heteromer P62826; Q9Y5L0; | 99.41 | 1×MG; 1×GTP; | |||
| Crystal Structure of Importin 13 - RanGTP - eIF1A complex |
Heteromer O94829; P47813; P62826; | 99.41 | 1×GTP; 1×MG; | |||
| Sirt2 in complex with a 13-mer trifluoroacetylated Ran peptide |
Heteromer P62826; Q8IXJ6; | 100 | 1×SO4; 1×ZN; | |||
| CANINE GDP-RAN | homo-2-mer | 99.5 | 2×MG; 2×GDP; | |||
| NMR solution structure of nucleotide-free Ran GTPase | monomer | 100 | ||||
| Structural Characterization of the Mengovirus Leader Protein Bound to Ran GTPase by Nuclear Magneti… | monomer | 100 | ||||
| Nucleotide-free human ran gtpase | monomer | 100 | ||||
| Crystal structure of human RanGDP | monomer | 100 | 1×MG; 1×GDP; | |||
| CANINE GDP-RAN F72Y MUTANT | monomer | 99.5 | 1×MG; 1×GDP; | |||
| CANINE GDP-RAN Q69L MUTANT | monomer | 99.5 | 1×MG; 1×GDP; | |||
| CANINE GDP-RAN R76E MUTANT | monomer | 99.5 | 1×MG; 1×GDP; | |||
| Ran GDP wild type tetragonal crystal form | monomer | 100 | 1×GDP; 1×MG; | |||
| Ran GDP Y39A mutant monoclinic crystal form | monomer | 99.5 | 1×GDP; 1×MG; | |||
| Ran GDP wild type monoclinic crystal form | monomer | 100 | 1×GDP; 1×MG; | |||
| Ran GDP Y39A mutant triclinic crystal form | monomer | 99.49 | 1×GDP; 1×MG; | |||
| crystal structure of human REV7-RAN complex | monomer | 100 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4gpt.1.A | monomer | 0.83 | 1×GNP; | 100.00 | ||